Geron is a small biotech company that recently received FDA approval for the first-in-class drug Imetelstat for the treatment of myelodysplastic syndrome. MDS is a blood disorder with a high mortality ...

Amy Fontinelle is a freelance writer, researcher and editor who brings a journalistic approach to personal finance content. Since 2004, she has worked with lenders, real estate agents, consultants, ...

The recent performance of LW in 3Q23 was exceptional, with strong pricing growth and product mix leading to higher margins and better-than-expected results. Margins are already at all-time highs, ...

SAN FRANCISCO--(BUSINESS WIRE)--Seniorly, the leading senior housing marketplace and technology company, unveiled the launch of its new estimated pricing model, a revolutionary advancement in the ...

Navigating healthcare can be tricky, and we want to make things as clear as possible. The prices provided below are intended to give self-pay patients an estimate of the prices for commonly provided ...

Philip Morris International Inc. PM posted robust second-quarter 2023 results, wherein the top and bottom lines increased year over year and beat the Zacks Consensus Estimate. The company continued to ...

Price targets estimate future stock prices, guiding buying or selling decisions. Analysts calculate these using factors like P/E ratios. Understanding targets helps investors anticipate stock ...

Affiliate links for the products on this page are from partners that compensate us (see our advertiser disclosure with our list of partners for more details). However, our opinions are our own. See ...

Altria Group Inc. MO posted fourth-quarter 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Earnings increased year over year while net revenues essentially came in ...

Tyson Foods, Inc. (TSN) reported solid fourth-quarter fiscal 2025 results, wherein earnings and sales increased year over year, and the bottom line beat the Zacks Consensus Estimate. Results ...